Latest AI and machine learning research in parkinson's disease for healthcare professionals.
BACKGROUND: Parkinson's disease (PD) ranks as the second most frequently occurring neurodegenerative disease. The precise pathogenic mechanism of this disease remains unknown. The aim of the present study was to identify the biomarkers in PD and classify the primary differentially expressed genes (DEGs).
Patients with advanced Parkinson's disease regularly experience unstable motor states. Objective and reliable monitoring of these fluctuations is an unmet need. We used deep learning to classify motion data from a single wrist-worn IMU sensor recording in unscripted environments. For validation purposes, patients were accompanied by a movement disorder expert, and their motor state was passively e...
BACKGROUND: Up to 90% of patients with Parkinson's disease (PD) eventually develop the speech and voice disorder referred to as hypokinetic dysarthria...
We show that machine learning can pinpoint features distinguishing inactive from active states in proteins, in particular identifying key ligand bindi...
OBJECTIVES: Remote assessment of gait in patients' homes has become a valuable tool for monitoring the progression of Parkinson's disease (PD). Howeve...
An underwater manipulator is essential for underwater robotic sampling and other service operations. Conventional rigid body underwater manipulators g...
In the last few years, the importance of measuring gait characteristics has increased tenfold due to their direct relationship with various neurologic...
BACKGROUND: Progressive supranuclear palsy (PSP), a neurodegenerative conditions may be difficult to discriminate clinically from idiopathic Parkinson...
Classic motion abnormalities in Parkinson's disease (PD), such as tremor, bradykinesia, or rigidity, are well-covered by standard clinical assessment...
BACKGROUND: Recognition of human behavioral activities using local field potential (LFP) signals recorded from the Subthalamic Nuclei (STN) has applic...
Untargeted metabolomics may become a standard approach to address diagnostic requests, but, at present, data interpretation is very labor-intensive. T...
PURPOSE: Visibility of nigrosome 1 in the substantia nigra (SN) is used as an MR imaging biomarker for Parkinson's disease. Because of lower susceptib...
Some applications are very sensitive to the weight of the robot, such as space manipulation or any untethered mobile manipulation. In this article, we...
OBJECTIVE: To assess the classification performance between Parkinson's disease (PD) and normal control (NC) when semi-quantitative indicators and sha...
Tracking symptoms progression in the early stages of Parkinson's disease (PD) is a laborious endeavor as the disease can be expressed with vastly diff...
Parkinson's disease (PD) is the second most common neurodegenerative disease, and α-synuclein plays a critical role in the pathogenesis of PD. Studie...
Neurodegenerative diseases are excessively affecting millions of patients, especially elderly people. Early detection and management of these diseases...
PURPOSE: It is vital to appropriately power clinical trials towards discovery of novel disease-modifying therapies for Parkinson's disease (PD). Thus,...
OBJECTIVE: Deep brain stimulation (DBS) of the internal segment of the globus pallidus (GPi) in patients with Parkinson's disease and dystonia improve...
This paper dispenses an exhaustive review on deep learning techniques used in the prognosis of eight different neuropsychiatric and neurological disor...